https://www.selleckchem.com/pr....oducts/danirixin.htm
94 (95% CI = 0.90-0.98) and 0.93 (95% CI = 0.89-0.98). Patients with T2DM who received ≥300 cDDD of metformin or used metformin with intensity of ≥10 DDD/month experienced no neuroprotective effects after 3 or 5 years. Metformin was associated with PD odds in T2DM in a dose-response association manner. Patients who received low dosage and intensity of metformin use were associated with lower odds of PD, while higher dosage and intensity of metformin use had no neuroprotective effect. Metformin was associated with PD odds in T2DM in a
Like
Comment
Share
